Alcohol Withdrawal
2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Colorado TherapeuticsCO - Louisville
2 programs1
KetaminePhase 41 trial
Patient navigationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Colorado TherapeuticsKetamine
Oregon TherapeuticsRiboflavin
Colorado TherapeuticsPatient navigation
Clinical Trials (3)
Total enrollment: 246 patients across 3 trials
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal
Start: Feb 2018Est. completion: Dec 20180
Phase 4Withdrawn
Riboflavin for Glutamate Reduction in Alcohol Withdrawal
Start: Dec 2021Est. completion: Oct 202240 patients
Phase 2Unknown
NCARE, Transition to Recovery
Start: Jun 2019Est. completion: Nov 2024206 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.